EcoDrugPlus

Melanocortin 3 Receptor

Ensembl ID : ENSEEEG00000011379
Gene Symbol: MC3R
1 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSEEEG00000009660
Gene Symbol: MC4R
4 Cross references
202 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSEEEG00000000326
Gene Symbol: MC4R
1 Cross references
153 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSEEEG00000020424
Gene Symbol: MTNR1A
4 Cross references
138 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSEEEG00000018070
Gene Symbol: MTNR1AA
4 Cross references
190 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSEEEG00000012255
Gene Symbol: MME
4 Cross references
234 Possible Orthologues:

Methionyl Aminopeptidase 2b

Ensembl ID : ENSEEEG00000004472
Gene Symbol: METAP2B
2 Cross references
228 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSEEEG00000008873
Gene Symbol: MAPK1
4 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSEEEG00000016536
Gene Symbol: MAPK10
2 Cross references
220 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSEEEG00000001597
Gene Symbol: MAPK11
4 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSEEEG00000007292
Gene Symbol: MAPK14
4 Cross references
191 Possible Orthologues:

Mitogen-Activated Protein Kinase 14b

Ensembl ID : ENSEEEG00000006969
Gene Symbol: MAPK14B
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).